The Impact of Culture in Cognitive Behavior Therapy (CBT) for Patients With Inflammatory Bowel Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Inflammatory Bowel Disease (IBD)Cognitive Behavior Therapy
Interventions
OTHER

cognitive-behavioral therapy

The treatment will consist of eight weekly sessions, each lasting one hour. The first session will focus on the rationale of cognitive behavioral therapy, i.e. the influence of (irrational or dysfunctional) cognitions and attitudes on (restrictive) feelings and behaviors. Additionally, goal setting will be initiated. Since patients may have a wide diversity of psychiatric problems (i.e. PTSD, anxiety disorders and depression), the treatment manual will encompass five optional modules for the therapist that focus on each of these disorders (i.e. exposure based for anxiety and PTSD, behavioral activation for depression). The subsequent sessions (2-6) will target teaching the patient to identify and challenge dysfunctional cognitions and attitudes related to IBD. Each session will address specific illness-related cognitions. If possible, dysfunctional cognitions and attitudes will be replaced by helpful cognitions and attitudes.

OTHER

Wait first, then cognitive-behavioral therapy

participants assigned to the waiting-list control condition will wait 3.5 months before they are treated with CBT. This period corresponds to the duration of the CBT intervention and follow-up assessment of the experimental group. After this 3.5 month waiting period the participants in the waiting-list control condition will be asked to complete a follow-up after waiting/baseline before CBT assessment before starting treatment.

Trial Locations (1)

310058

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Wang Zhen

OTHER

NCT06713694 - The Impact of Culture in Cognitive Behavior Therapy (CBT) for Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter